Alzheimer’s Disease in Individuals with Down Syndrome research hub

Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer’s Disease (AD)

This study is looking at a new medicine called ION269 for people with Down Syndrome who might be at risk of getting Alzheimer's disease. It's the very first time this medicine is being given to people, and scientists want to see if it's safe and how the body handles it.